Stocks and Investing Stocks and Investing
Tue, May 14, 2024

Leland Gershell Maintained (URGN) at Buy with Decreased Target to $32 on, May 14th, 2024


Published on 2024-10-28 11:21:11 - WOPRAI, Leland Gershell
  Print publication without navigation


Leland Gershell of Oppenheimer, Maintained "UroGen Pharma Ltd." (URGN) at Buy with Decreased Target from $34 to $32 on, May 14th, 2024.

Leland, nor any peers, have made any analyst calls on URGN in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30

Contributing Sources